(Q43234583)

16 November 2017

title

Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation (English)

1 reference

16 November 2017

1 reference

Sheetu Wadhwa

1

1 reference

16 November 2017

Rishi Paliwal

series ordinal

2

1 reference

16 November 2017

Shivani R Paliwal

series ordinal

3

1 reference

16 November 2017

S P Vyas

series ordinal

4

1 reference

16 November 2017

publication date

1 May 2010

1 reference

Journal of Drug Targeting

16 November 2017

published in

1 reference

16 November 2017

volume

18

1 reference

16 November 2017

issue

4

1 reference

16 November 2017

page(s)

292-302

1 reference

Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

Recent advances on chitosan-based micro- and nanoparticles in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

The potential of chitosan in ocular drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

In vitro alternatives for ocular irritation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

Bioadhesive hyaluronan-chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

Novel hyaluronan-based nanocarriers for transmucosal delivery of macromolecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

Effect of chitosan on in vitro release and ocular delivery of ofloxacin from erodible inserts based on poly(ethylene oxide).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

Simultaneous determination of dorzolamide HCL and timolol maleate in eye drops by two different spectroscopic methods

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

Antioxidant activity of timolol on endothelial cells and its relevance for glaucoma course.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

The use of mucoadhesive polymers in ocular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

Understanding mechanisms of pressure-induced optic nerve damage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

Chitosan-based particles as controlled drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous drops

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

Glaucomatous outflow pathway and oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

Ultrasonication of chitosan and chitosan nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

Chitosan and its derivatives as intestinal absorption enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

Topical formulations and wound healing applications of chitosan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

Challenges and obstacles of ocular pharmacokinetics and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

Nanocarriers in ocular drug delivery: an update review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903450023

10.3109/10611860903450023

21 January 2018

Identifiers

DOI

1 reference

16 November 2017

1 reference